Summary
We report on a patient with splenic lymphoma of B-cell origin who developed autoimmune hemolytic anemia (AIHA). IgMλ M-protein, IgM anticardiolipin antibody (ACA), and lupus anticoagulant (LA) were detected in the serum, and direct Coombs' test showed autoantibodies of the IgG1 and IgG2 subclasses on red blood cells (RBC). In in vitro culture, tumor cells isolated from the spleen produced only IgM ACA, which was enhanced by IL-6 but not by IL-4 or IL-5. The levels of ACA and LA decreased after splenectomy and chemotherapy; the strength of the direct Coombs' test, however, did not change. These findings indicated that in this patient the lymphoma cells produced IgMλ. ACA, but not autoantibodies of the IgG1 and IgG2 subclasses against RBC. It was also suggested that IL-6 might at least partially stimulate the production of ACA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bellotti V, Gamba G, Merlini G, Montani N, Bucciarelli E, Stoppini M, Ascari E (1989) Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol 73:221–227
Borche L, Lim A, Binet JL, Dighiero G (1990) Evidence that chronic lymphocytic leukemic B lymphocytes are frequently committed to productions of natural autoantibodies. Blood 76:562–569
Brox A, Bishinsky JI, Berry G (1991) Primary non-Hodgkin lymphoma of the spleen. Am J Hematol 38:95–100
Ciaudo M, Horellou MH, Audouin J, De Carbonnieres C, Conard J, Samama M (1991) Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients. Am J Hematol 38:271–276
Deane M, Norton JD (1990) Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B-lineage leukemias. Eur J Immunol 20:2209–2217
Dighiero G, Hart S, Lim A, Borche L, Levy R, Miller RA (1991) Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 78:581–585
Falk S, Stutte HJ (1990) Primary malignant lymphoma of the spleen. A morphologic and immunohistochemical analysis of 17 cases. Cancer 66:2612–2619
Harris EN (1990) Antiphospholipid antibodies. Br J Haematol 74:1–9
Kehoe J, Straus DJ (1988) Primary lymphoma of the spleen: clinical features and outcome after splenectomy. Cancer 62:1433–1438
Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S (1984) Anti-phospholipid antibodies and biological false-positive serological test for syphilis in patients with lupus erythematosus. Clin Exp Immunol 56:193–199
Lundgren M, Persson U, Larsson P, Magnusson C, Smith CIE, Hammarstrom L, Severinson E (1989) Interleukin-4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 19:1311–1315
McNeil HP, Chesterman CN, Krilis SA (1989) Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73:506–513
Morel P, Dupriez B, Gosselin B, Fenaux P, Estienne MH, Facon T, Jouet JP, Bauters F (1992) Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). Cancer 71:207–215
Moridaira K, Murakami H, Kitahara T, Tamura J, Matsushima T, Sawamura M, Naruse T, Kubota K, Tsukamoto N, Sato S, Tsuchiya J (1993) Spurious macrocytosis associated with non-Hodgkin's lymphoma: report of two cases. Ann Hematol 66:55–56
Murakami H, Tamura J, Sawamura M (1993) MCNU in the treatment of essential thrombocythemia — a pilot study. Ann Hematol 66:247–249
Pene J, Rousset F, Briere F, Chretien I, Wademan J, Bonnefory JY, De Vries JE (1988) Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 18:929–935
Pengo V, Thiagarajan P, Shapiro SS, Heine MJ (1987) Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 70:69–76
Rosove MH, Ismail M, Koziol BJ, Runge A, Kasper CK (1986) Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood 68:472–478
Roubey RAS, Pratt CW, Buyon JP, Winfield JB (1987) Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J Clin Invest 90:1100–1104
Sawamura M, Everson MP, Shrestha K, Ghanta VK, Miller DM, Hiramoto RN (1990) Characterization of 5B12.1, a monoclonal antibody specific for IL-6. Growth Factors 3:181–190
Snapper CM, Finkelman FD, Paul WE (1988) Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med 167:183–196
Sthoeger ZM, Wakai M, Tse DB, Vinciguerra VP, Allen SL, Budman DR, Lichtman SM, Schulman P, Weiselberg LR, Chiorazzi N (1989) Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 169:255–268
Thiagarajan P, Shapiro SS, De Marco L (1980) Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of lupus anticoagulant. J Clin Invest 66:397–405
Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS (1989) Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol 19:1419–1424
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawamura, M., Yamaguchi, S., Murakami, H. et al. Multiple autoantibody production in a patient with splenic lymphoma. Ann Hematol 68, 251–254 (1994). https://doi.org/10.1007/BF01737426
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01737426